1038919-82-2

Upstream product

• 34598-49-7 5-Bromo-1-indanone 
• 1038919-63-9 (R)-5-bromo-2,3-dihydro-1H-inden-1-ol 
• 144873-97-2 2-(N-triphenylmethyl-tetrazol-5-yl)-phenylboronic acid 

Downstream Products

• 1310692-62-6 (S)-3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2,5-diethyl-7-methyl-3H-imidazo[4,5-b]pyridine 
• 1310693-01-6 (S)-2,5-diethyl-7-methyl-3-(5-(2-(1-trityl-1H-tetrazol-5-yl)-phenyl)-2,3-dihydro-1H-inden-1-yl)-3H-imidazo[4,5-b]pyridine 
• 1310692-66-0 (S)-3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-7-isobutyl-5-methyl-3H-imidazo[4,5-b]pyridine 
• 1310693-05-0 (S)-2-ethyl-7-isobutyl-5-methyl-3-(5-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-3H-imidazo[4,5-b]pyridine 
• 1310693-03-8 (S)-2-ethyl-5-isobutyl-7-methyl-3-(5-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-3H-imidazo[4,5-b]pyridine 
• 1310692-64-8 (S)-3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo[4,5-b]pyridine 
• 1310692-57-9 (S)-3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-5,7-dimethyl-2-propyl-3H-imidazo[4,5-b]pyridine 
• 1310692-95-5 (S)-5,7-dimethyl-2-propyl-3-(5-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-3H-imidazo[4,5-b]pyridine 
• 1310692-98-8 (S)-2-cyclopropyl-5,7-dimethyl-3-(5-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-3H-imidazo[4,5-b]pyridine 
• 1310692-59-1 (S)-3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-cyclopropyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine 
• 1421597-66-1 C₄₉H₄₂N₈O₂ 
• 1421597-85-4 C₃₀H₂₈N₈O₂ 
• 1421597-65-0 C₄₉H₄₀N₈O 
• 1421597-84-3 C₃₀H₂₆N₈O 

Relevant academic research and scientific papers

Discovery of a series of imidazo[4,5-b ]pyridines with dual activity at angiotensin II Type 1 receptor and peroxisome proliferator-activated receptor-γ

Mining of an in-house collection of angiotensin II type 1 receptor antagonists to identify compounds with activity at the peroxisome proliferator-activated receptor-γ (PPARγ) revealed a new series of imidazo[4,5-b]pyridines 2 possessing activity at these